Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
PROCAPS GROUP Aktie jetzt für 0€ handeln | |||||
13.05. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
09.04. | Procaps Group, S.A.: Procaps Group Secures $130 Million in Equity Investment and Completes Comprehensive Debt Restructuring, as New Investors Take Over Strategic Leadership | 109 | GlobeNewswire (Europe) | New Investors Take Over the Strategic Leadership as Headquarters Move to Bogotá, Marking the Start of a New Chapter of Growth, Execution, and Transformation under Enhanced Governance Company Accelerates... ► Artikel lesen | |
09.04. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
25.03. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
06.03. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
19.02. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
17.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.02.2025 | 1.505 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 17.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.02.2025ISIN NameCA00208E3077 ATI... ► Artikel lesen | |
04.02. | Nasdaq delists Colombia's Procaps Group due to financial shortfalls | 1 | iNVEZZ.com | ||
04.02. | XFRA 9X1: AUSSETZUNG/SUSPENSION | 335 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPROCAPS GRP S.A.... ► Artikel lesen | |
03.02. | Procaps Group, S.A.: Procaps Group Receives Delisting Notice From Nasdaq | 395 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
03.02. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
03.01. | Procaps Group, S.A.: Procaps Group Receives Additional Delinquency Letter | 320 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
20.12.24 | Procaps Group, S.A.: Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates | 323 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
03.12.24 | Procaps Group, S.A.: Procaps Group Announces Financing, Shareholders Agreement and Board Updates | 218 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
29.11.24 | Pre-market Movers: Bolt Projects, Applied Therapeutics, Primega Group, Procaps Group, SKK Holdings | 1.041 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.25 A.M. ET).In the Green Bolt Projects Holdings, Inc. (BSLK) is up over 233%... ► Artikel lesen | |
16.11.24 | Procaps Group, S.A.: Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing | 356 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), announced today that, on November 13, 2024, the Company received... ► Artikel lesen | |
10.10.24 | Procaps Group, S.A.: Procaps Issues Shareholder Letter Update | 271 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
18.09.24 | Procaps Group, S.A.: Procaps Issues Shareholder Letter Update | 433 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
03.09.24 | Procaps Group, S.A.: Procaps Issues Shareholder Letter | 202 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical conglomerate... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 3,910 | +1,69 % | Stocks in Play: Aurora Cannabis Inc. | ||
CANOPY GROWTH | 0,970 | +2,86 % | Down an Incredible 99% From All-Time Highs, Is Canopy Growth Stock Worth Buying Now? | ||
TILRAY BRANDS | 0,533 | +2,86 % | Tilray Brands, Inc.: Breckenridge Distillery Launches Mock One: Bold, Premium Non-Alcoholic Alternatives to Whiskey, Tequila, Gin & Rum - Crafted for Everyone Who Loves a Great Drink | ||
TEVA | 14,100 | +2,17 % | Teva Pharma stock rating reiterated at Buy by BofA on Austedo growth | ||
VERTEX PHARMACEUTICALS | 404,30 | +1,25 % | Vertex Pharmaceuticals Incorporated: Vertex Announces Broad Reimbursement Agreement With NHS England for ALYFTREK (Deutivacaftor/Tezacaftor/Vanzacaftor) an Innovative Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis | All eligible people with CF in England can now benefit from this medicine - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that it has reached a broad reimbursement agreement... ► Artikel lesen | |
ARZNEIWERK AG VIDA | 0,424 | -15,20 % | XETR DELETION OF INSTRUMENTS FROM XETRA - 30.06.2025 | The following instruments on XETRA do have their last trading day on 30.06.2025Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 30.06.2025ISIN NameDE000A3EX3G0 GORE German Office... ► Artikel lesen | |
CRONOS GROUP | 1,786 | +3,12 % | High Tide schließt mit Cronos Group Inc. eine Vereinbarung über Wandelschuldverschreibungen im Wert von 30 Millionen $ ab | CALGARY, AB, und TORONTO, ON, 16. Juli 2025 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA), das
erfolgreiche, auf den Einzelhandel fokussierte... ► Artikel lesen | |
VIATRIS | 8,000 | +2,56 % | Viatris Certified as a Great Place to Work in Canada | ||
INCYTE | 59,52 | 0,00 % | Incyte: UBS erhöht Kursziel auf 62 US-Dollar aufgrund von Verkaufsaussichten | ||
BAUSCH HEALTH | 5,638 | +1,79 % | Bausch Health Companies Inc: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, CABTREO, Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs | LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that PrCABTREOTM (clindamycin phosphate, adapalene... ► Artikel lesen | |
IONIS PHARMACEUTICALS | 36,620 | -0,38 % | Ionis Pharmaceuticals: Spannender Ausblick | Das US-Biotechunternehmen Ionis Pharmaceuticals durchläuft derzeit eine hochspannende Phase. Ionis gilt als Pionier auf dem Gebiet der Antisense-Oligonukleotid-(ASO)-Technologie. In der Fachzeitschrift... ► Artikel lesen | |
CRESCO LABS | 0,464 | +3,25 % | Cresco Labs Inc: Cresco Labs terminates auditor Marcum | ||
ALNYLAM PHARMACEUTICALS | 275,80 | +4,15 % | Alnylam Pharmaceuticals stock price target raised to $290 by Cantor Fitzgerald | ||
NEKTAR THERAPEUTICS | 22,500 | +8,43 % | Nektar Therapeutics Prices $100 Mln Public Offering Of Common Stock At $23.50 Per Share | WASHINGTON (dpa-AFX) - Nektar Therapeutics (NKTR), a clinical-stage biotech firm specializing in immunotherapy, has priced its underwritten public offering of approximately $100 million in common... ► Artikel lesen | |
ORAMED PHARMACEUTICALS | 1,810 | 0,00 % | ORAMED PHARMACEUTICALS INC. - 10-K/A, Annual Report |